glp-1 weight loss drug news today 2025 Drugs Revolutionize Market in the United States GLP-1 weight-loss drugs may soon

These results indicate that switching to injectable semaglutide from any other GLP-1 RA leads to improvement in both glycaemic control and weight, effects that are apparent after 12 months of treatment

Nystrm T, et al

Briefly, FFAs can reduce the tyrosine phosphorylation of insulin receptor substrate-1 by activating the serine/threonine kinase, thereby aggravating IR (151)

We depart early after breakfast

In a warning letter dated 1 April, FDA inspectors cited Pure Indulgence Aesthetics for several DSCSA violations, including potentially selling products from a company or companies that were not authorized trading partners